ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 171 filers reported holding ALLOGENE THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.29 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,789,000 | -19.9% | 258,214 | -15.4% | 0.24% | -19.7% |
| Q2 2022 | $3,480,000 | -23.8% | 305,253 | -39.1% | 0.30% | -17.6% |
| Q1 2022 | $4,566,000 | -69.3% | 501,219 | -49.7% | 0.36% | -62.3% |
| Q4 2021 | $14,862,000 | -36.8% | 996,116 | +8.9% | 0.95% | -35.0% |
| Q3 2021 | $23,500,000 | +16.5% | 914,416 | +18.2% | 1.46% | +42.6% |
| Q2 2021 | $20,174,000 | +6.5% | 773,562 | +44.1% | 1.02% | -18.6% |
| Q1 2021 | $18,947,000 | – | 536,738 | – | 1.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 1,798,163 | $5,700,177 | 8.82% |
| Wildcat Capital Management, LLC | 1,920,787 | $6,088,895 | 2.44% |
| TPG GP A, LLC | 18,716,306 | $59,330,690 | 1.02% |
| EcoR1 Capital, LLC | 4,488,200 | $14,227,594 | 0.48% |
| CROSSPOINT FINANCIAL, LLC | 12,000 | $38,040 | 0.40% |
| Coastal Bridge Advisors, LLC | 406,847 | $1,289,705 | 0.35% |
| CAXTON ASSOCIATES LP | 480,104 | $1,521,930 | 0.21% |
| Woodline Partners LP | 5,313,915 | $16,845,111 | 0.20% |
| Rhenman & Partners Asset Management AB | 300,000 | $951,000 | 0.10% |
| Navalign, LLC | 75,365 | $238,907 | 0.09% |